about
Role of Neutrophil CD64 Index as a Screening Marker for Late-Onset Sepsis in Very Low Birth Weight InfantsEarly feeding advancement in very low-birth-weight infants with intrauterine growth retardation and increased umbilical artery resistance.Late-onset volvulus without malrotation in extremely preterm infants--a case-control-study.Effect of different assumptions for brain water content on absolute measures of cerebral oxygenation determined by frequency-domain near-infrared spectroscopy in preterm infants: an observational study.Utility of salivary melatonin measurements in the assessment of the pineal physiology in newborn infants.Pyridoxal phosphate-dependent neonatal epileptic encephalopathy.Early feeding of fortified breast milk and in-hospital-growth in very premature infants: a retrospective cohort analysis.Repeatability of echocardiographic parameters to evaluate the hemodynamic relevance of patent ductus arteriosus in preterm infants: a prospective observational study.A review of cord blood concentrations of iron status parameters to define reference ranges for preterm infants.Avoiding postnatal undernutrition of VLBW infants during neonatal intensive care: evidence and personal view in the absence of evidence.Effect of Increased Enteral Protein Intake on Growth in Human Milk-Fed Preterm Infants: A Randomized Clinical Trial.Choline and polyunsaturated fatty acids in preterm infants' maternal milk.Growth and morbidity of extremely preterm infants after early full enteral nutrition.Transport of long-chain polyunsaturated fatty acids in preterm infant plasma is dominated by phosphatidylcholine.Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessments.Short-Term Effects of Blood Transfusions on Hepcidin in Preterm Infants.Automated FiO2 control: nice to have, or an essential addition to neonatal intensive care?Choline supply of preterm infants: assessment of dietary intake and pathophysiological considerations.The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury.Whole blood interleukin 8 and plasma interleukin 8 levels in newborn infants with suspected bacterial infection.Developmental changes in polyunsaturated fetal plasma phospholipids and feto-maternal plasma phospholipid ratios and their association with bronchopulmonary dysplasia.Congenital chylothorax: a prospective nationwide epidemiological study in Germany.Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial.Partial liquid ventilation in severely surfactant-depleted, spontaneously breathing rabbits supported by proportional assist ventilation.Pulmonary administration of perfluorodecaline- gentamicin and perfluorodecaline- vancomycin emulsions.Detection of astrovirus in premature infants with necrotizing enterocolitis.Hydrolysis of casein accelerates gastrointestinal transit via reduction of opioid receptor agonists released from casein in rats.Gestational age-specific reference ranges of hepcidin in cord blood.A pilot study of the pleth variability index as an indicator of volume-responsive hypotension in newborn infants during surgery.Rational approach to the diagnosis of severe growth hormone deficiency in the newborn.No evidence from controlled trials to support the hypothesis that slow feeding advancement in preterm infants reduces the risk of necrotizing enterocolitis. Reply to the letter to the editor by S. Meyer and M. Butte: feeding regimens and necrotisingSaliva as a valid alternative in monitoring melatonin concentrations in newborn infants.Plasma phospholipids indicate impaired fatty acid homeostasis in preterm infants.Retrospective cohort analysis on pancreatic enzyme substitution in very low birthweight infants with postnatal growth failure.Short-, medium-, and long-term assessment of pulmonary dysfunction in extremely low birth weight neonates.Prospective randomized trial of early versus late enteral iron supplementation in infants with a birth weight of less than 1301 grams.Measurement of interleukin 8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants: a multicenter, randomized, controlled trial.Allopurinol: old drug, new indication in neonates?Accuracy of pulse oximetry readings in an animal model of low perfusion caused by emerging pneumonia and sepsis.Healthy term and moderately preterm infants have similar cerebral oxygen saturation and cerebral blood flow volumes during early post-natal transition.
P50
Q28546544-4CAF6A37-3218-4A7D-976F-B107D3B5434DQ30843949-262E4E1D-2C36-41EF-8213-63B7AE6AC036Q33463309-30EC0F4B-F518-4CF5-9D60-825C6D0E420CQ34088977-EAD91DA4-E8FD-4089-A4E5-D2793E2E59C3Q34113106-9C04839E-0EB3-4290-BC1D-01A5140A151EQ34526692-572287DE-C6DB-45F3-B5B8-FE231FA2B89EQ35030193-CE399C22-E7B5-4839-B6AB-BDF09ABE4D0AQ35904522-D44D8DF4-3BD5-4E75-BBED-246FD74F6D24Q38132566-050735D3-2C5A-4AFB-B1BF-E238955378D1Q38256544-02FA58D9-D42A-444E-8B3F-765DE79CC4E4Q38384182-D196A9BB-A859-4CFC-99B7-199FB5D1A0F6Q38392731-ACB990A9-5EC6-4C80-BF3D-BC61C52A0A03Q38667203-24A39703-B7F0-4567-B174-5A24B5547B80Q38668215-CA1CED2B-12AA-4007-AC3F-63CCCA17E454Q38942492-AA4E20E2-F69D-4114-A126-CEB640B9A5D9Q38971155-7BBA084E-CE7D-4F5C-9818-6848E6ABA761Q38971311-F4AD2D0F-5D35-4C4F-B994-DC9716FECF6DQ39555876-7B719596-61C8-4C96-9FD2-A6B00DF66407Q40200067-9D5CE5DD-0D9B-411D-B484-707A6418D817Q40506691-8A55FA44-9F38-4678-9CCC-32A92E35F337Q40546104-32488F90-7EA6-4BBD-93F3-DE36389CE038Q41722253-8A0FA38F-7E06-4FFE-BB8C-E448B9220150Q42152343-F0DF6340-2B79-4308-AF95-D5FBCCD64517Q43632179-AC22CF24-7B9E-4A5C-BB17-BC6EE97DBE4CQ43806469-E7DECDCD-07D7-41AE-BBB9-AEAD867563B8Q43872568-168CC109-D4FA-464C-958A-A3667039DDE0Q44347426-B3AE13CB-A4AB-41A8-9EFC-0B8A053C65B6Q44799502-1C9AF2C6-ECBF-4B08-A0F6-BA865FEFFFCAQ45234808-A122BD79-CEC3-413B-9DA2-F8A4C5D56DE6Q45729455-5DF7140C-7C86-4507-9D85-F71660B4E63EQ45839378-C7091D48-4A7F-4819-A938-3F4A0DAB2DA4Q45925925-4E70B3DD-35C7-494D-A568-7069F7703D00Q46941235-888FC984-3B97-48A1-9009-49110EB50DD8Q47184335-798D29DE-F7DC-4019-82E9-25095D3B09E0Q47205469-4F8B1B59-AFB4-49F3-BD10-F4D3D8C21234Q47228266-75559986-F3AA-4F34-8CEF-8940DA481EBAQ47253289-604A8447-EAFE-4240-BA18-CE2298A97350Q47962431-CEECD4F7-8222-4978-8491-76BF1C5941E9Q48031464-6CF43F1D-779E-4474-B527-191DBBF8AB29Q48233036-B8C303BE-527D-4849-8A3D-4AE368DDFC24
P50
description
researcher ORCID ID = 0000-0001-5066-0857
@en
wetenschapper
@nl
name
Axel Franz
@ast
Axel Franz
@en
Axel Franz
@es
Axel Franz
@nl
type
label
Axel Franz
@ast
Axel Franz
@en
Axel Franz
@es
Axel Franz
@nl
prefLabel
Axel Franz
@ast
Axel Franz
@en
Axel Franz
@es
Axel Franz
@nl
P106
P31
P496
0000-0001-5066-0857